CELC
Celcuity Inc.
$107.58
-5.93 (-5.22%)
At close · Jul 10
Market Cap
$5.30B
Shares
48,766,288
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$107.58
Open$113.50
Day$107.25–113.50
52W$13.35–151.02
Avg vol 30d1.6M
Short int11.0M · 22.5% float · 8.6d
Short vol71%
Last earningsMay 14, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 14
Up next
Next earnings call
Aug 13, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+7%
above
Price vs 50-day avg
−5%
below
RSI (14)
53
neutral
MACD trend
Positive
52-week position
68%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+22%
trailing
6-month return
+2%
trailing
YTD return
+8%
this year
Relative strength
−7%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $113 › 200d $101 — 50d above 200d
Institutional flow
Accumulating
8 of 278 funds reported for Jun 30 · net +102.7K sh shares · +1 new
Insider flow
Distributing
Net -$4.8M over 90 days · 100% sells
Short interest
Rising
22.49% of float · ▲ +2.8% MoM · 8.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
278 holders — near 3-yr high, broad support
Squeeze score
89
high risk · 0–100
Fundamentals
EPS growth
−34%
Y/Y
Free cash flow
$-153.5M
Balance sheet
$28.2M
net cash
Quant / Vol
risk profile
Volatility
183%
annualized · 1-yr
Max drawdown
−40%
past year
ATR
6.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+7%
Bullish
Price vs 50-day avg
−5%
Neutral
RSI (14)
53
Neutral
MACD trend
Positive
Bullish
52-week position
68%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $113 › 200d $101 — 50d above 200d
Institutional flow
Accumulating
8 of 278 funds reported for Jun 30 · net +102.7K sh shares · +1 new
Insider flow
Distributing
Net -$4.8M over 90 days · 100% sells
Short interest
Rising
22.49% of float · ▲ +2.8% MoM · 8.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
278 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $13
Now $108 · 68%
52-wk high $151
vs 200-day avg +7%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CELC
this stock
Celcuity Inc.
|
$5.30B | +7.9% | — | — | 22.5% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +9.5% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.63B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +8.2% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CELC | -0.3% | +21.9% | +2.2% | +2.8% | +7.9% |
| SPY | +0.8% | +2.0% | +8.9% | +0.7% | +10.2% |
| vs SPY | -1.1% | +19.9% | -6.7% | +2.2% | -2.4% |